A phase II randomized placebo-controlled study of fisetin to improve physical function in breast cancer survivors: the TROFFi study rationale and trial design. uri icon

authors

  • Ji, Jingran
  • Evans, Tamara
  • Tchkonia, Tamar
  • Kirkland, James L
  • Kuchel, George A
  • Cohen, Harvey Jay
  • Mina S. Sedrak, MD, MS
  • Crespi, Catherine M
  • Yee, Lisa
  • Zekster, Yuliya A
  • Al-Saleem, Ali
  • Petersen, Laura
  • Lee, Catherine
  • Son, Nala
  • Smith, Claire

publication date

  • March 11, 2026